Be a Smart Investor
Tuesday, May 3, 2022
Biogen Reaffirms FY22 Outlook; Q1 Adj. EPS Misses Estimates
While reporting financial results for the first quarter on Tuesday, Biogen Inc. (BIIB) reaffirmed its adjusted earnings and revenue guidance for the full-year 2022.
from RTT - Earnings https://ift.tt/njlQUB8
via
IFTTT
No comments:
Post a Comment
Newer Post
Older Post
Home
View mobile version
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment